Clinical Trials

Leukemia, Myeloid, Acute

NCT07306832 2025-12-29

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

18 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT07303660 2025-12-26

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

66 enrolled

Classical hematologyOther hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06906380 2025-12-08

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Not yet recruiting

49 enrolled

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT06281847 2025-09-18

RESOLVE AML001

143 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT07137637 2025-08-22

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

60 enrolled

Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

NCT07107126 2025-08-06

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

MyeloidOther hematologic neoplasm

18 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07084584 2025-07-24

An Open-label, Dose-Escalation and Dose-Expansion Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

184 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Leukemia, Myeloid, Acute

NCT06702098 2024-11-22

iNK-r/r AML

10 enrolled

Leukemia, Myeloid, Acute

NCT06463327 2024-06-17

ACHIEVE2

MyeloidOther hematologic neoplasm

69 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06441084 2024-06-04

A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation

15 enrolled

Leukemia, Myeloid, Acute

NCT06387420 2024-04-29

A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia

180 enrolled

Leukemia, Myeloid, Acute

NCT06347458 2024-04-04

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

24 enrolled

Phase 3 Not yet recruiting

Leukemia, Leukemia, Myeloid, Acute

NCT06182592 2023-12-28

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

120 enrolled

Neoplasm Metastasis, Leukemia, Myeloid, Acute

NCT05055791 2021-09-24

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies